British singer Lily Allen’s appearance as the musical guest on NBC's Saturday Night Live on Saturday night sparked a sharp backlash from some viewers, with social media users questioning her vocals, ...

Lily Allen returned to the Saturday Night Live stage after nearly 19 years away with two performances from her latest pop album, West End Girl. Allen, an SNL musical guest in early 2007, opened with ...

One of Eli Lilly’s most promising new obesity drugs helped patients lose about 28.7% of their body weight while also reducing pain associated with knee osteoarthritis. The drug giant’s LLY stock was ...

Shares of French biotech Abivax (ABVX) climbed in Paris on Wednesday, in a move Reuters attributed to market speculation about a potential takeover bid from weight-loss drugmaker Eli Lilly (LLY). The ...

Lily Allen is headed out on tour to promote her controversial, cult favorite album "West End Girl." The British singer, 40, will criss-cross North America for her biggest tour yet, beginning in Spring ...

Eli Lilly on Monday, Dec. 1 slashed prices of its blockbuster weight loss drug Zepbound for consumers who buy the prescription medication directly from the drugmaker. Lilly's price cuts ranged from ...

Drugmaker Eli Lilly is rolling out a new model to make it easier for employers to provide access to its GLP-1 drugs for weight management. Lilly said in an announcement that the model is built on ...

Anthony Mason is a senior culture and senior national correspondent for CBS News. He has been a frequent contributor to "CBS Sunday Morning." Vice President of Growth & Engagement at CBS News and ...

In this photo illustration, a Eli Lilly logo seen displayed on a smartphone. Eli Lilly’s stock (NYSE: LLY) has recently surged 27% over the past month, reaching a current price of $1,022. This rally ...

Both Eli Lilly and Novo Nordisk are denying a telehealth company’s claim of having struck partnerships with the two companies to provide direct access to their popular obesity meds. Thursday morning, ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...